Health Condition 1: O359- Maternal care for (suspected) fetal abnormality and damage, unspecified
Conditions
Interventions
Intervention1: INTERVENTION REGARDING SECOND TRIMESTER MEDICAL TERMINATION OF PREGNANCY: Patients will receive Tab Mifepristone 200 mg per orally followed by 1st dose of Tab Misoprostol 400 mcg by vag
Sponsors
NO MONETARY SUPPORT
Eligibility
Inclusion criteria
Inclusion criteria: 1 Maternal age between 18 to 45 years 2 Singleton pregnancy 3 Willing to participate in the study and ready to comply with the schedule of follow up visits
Exclusion criteria
Exclusion criteria: 1 Unmarried women 2 Multifoetal pregnancy 3 Lactating mothers 4 Previous uterine scars of any type 5 Any contraindication to Mifepristone i.e chronic adrenal failure,long term corticosteroid therapy, concurrent anticoagulant therapy,inherited porphyrias,undiagnosed adnexal mass 6 Any contraindication to Misoprostol i.e severe asthma, glaucoma,pelvic infections,hemodynamic instability,allergy to misoprostol,known bleeding disorder. 7 Uncontrolled hypertension with BP >160/110 mm hg 8 Any acute medical illness
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| INDUCTION TO EXPULSION INTERVALTimepoint: TIME INTERVAL BETWEEN INDUCTION WITH TAB MIFEPRISTONE AND EXPULSION OF PRODUCTS OF CONCEPTION | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare the completeness of abortion and to compare the side effects between the two regimenTimepoint: SIDE EFFECTS ASESSED EVERY 3 HOURLY AFTER INDUCTION WITH TAB MISOPROSTOL | — |
Countries
India
Contacts
Public ContactDR ROHIT MALLAPPA KAMAGOUDA
AIIMS RAIPUR
Outcome results
None listed